Darwin Wealth Management LLC Makes New $90,000 Investment in Humana Inc. (NYSE:HUM)

Darwin Wealth Management LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 285 shares of the insurance provider’s stock, valued at approximately $90,000.

A number of other institutional investors have also recently bought and sold shares of the business. Mendota Financial Group LLC boosted its position in Humana by 9.2% during the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 27 shares during the period. Capital Advisors Ltd. LLC raised its stake in shares of Humana by 17.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after purchasing an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its stake in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Harbour Investments Inc. lifted its holdings in Humana by 10.5% in the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after purchasing an additional 41 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft lifted its holdings in Humana by 1.0% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock worth $1,649,000 after purchasing an additional 42 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

HUM opened at $294.02 on Thursday. The stock has a market cap of $35.40 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 2.19 and a beta of 0.52. The business has a 50 day moving average of $277.86 and a 200-day moving average of $331.03. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, equities research analysts expect that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is 31.36%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Truist Financial lowered their price objective on Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft lowered their price target on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Oppenheimer decreased their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Finally, Barclays upped their price target on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.